Researchers Automated Bioprocessing Cell Monitoring
A new review highlights how electrical cell analysis and machine learning improve biomanufacturing speed.
Updated on Oct. 7, 2026 in Biotech
Live Poll
Do you trust automated machine learning systems to manage quality in pharmaceutical manufacturing?
Scientists have reviewed advances in dielectrophoresis that allow for label-free monitoring of cell culture health. This approach integrates electrical signature data with machine learning to enable real-time detection of apoptosis in bioprocessing.
Why it matters
Traditional methods for measuring cell apoptosis often provide delayed results, creating a major bottleneck in biologics manufacturing. Real-time electrical monitoring offers a path toward autonomous intervention and optimized harvesting cycles.
The 3DEP platform analyzes approximately 20,000 cells in seconds to detect electrical signatures. Viable cell conductivity measures 0.45 siemens per meter, while apoptotic cells drop to 0.05 siemens per meter.
The players
Alaleh Vaghef-Koodehi
She is a researcher affiliated with the University of Massachusetts Amherst who led the review on electrical cell monitoring.
Blanca Lapizco-Encinas
She is a co-author of the review and a faculty member at the Rochester Institute of Technology.
The details
Researchers examined advances from 2015 through 2026, finding that Chinese hamster ovary cells display distinct electrical phases during nutrient-starvation-induced apoptosis. By applying random-forest models to electrical impedance data, scientists achieved high accuracy in identifying dying cell populations that typically emerge between 24 and 36 hours.
Timeline
The review covered developments in cell monitoring from 2015 through 2026.
Apoptotic cell populations in the studied Chinese hamster ovary groups appeared between 24 and 36 hours.
A cytoplasmic conductivity measurement of 0.07 siemens per meter was documented at 52 hours.
A 2026 study integrated electrical impedance data with supervised machine learning.
The Tech Race
This research follows a pattern set by the National Institute for Innovation in Manufacturing Biopharmaceuticals to reduce production bottlenecks. It shifts the industry away from manual, time-delayed sampling toward fully autonomous, real-time biomanufacturing systems.
By accelerating the detection of cell health issues, this technology could reduce costs and lead times for the production of complex biologics. Developers and manufacturers may soon gain more granular control over batch quality, resulting in fewer failed production runs.
The takeaway
Integrating electrical sensing with machine learning bridges the gap between raw data collection and actionable process control. Implementing these automated signatures helps manufacturers move past the limitations of traditional, time-intensive cell monitoring.
Further reading
Find more on the evolution of automated systems in the Biotech section.
Source note: This article includes information reported by GEN - Genetic Engineering and Biotechnology News.
Live Poll
Do you trust automated machine learning systems to manage quality in pharmaceutical manufacturing?
